TapewireFind a company

person · Reporting owner

Johnson Michael Patrick

Disclosed activity across 1 company

Tapewire entity
147030
SEC CIK
0001816084

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
OCULUS INC.OTCQB · Entity 8451DirectorJuly 21, 2020August 24, 2020

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

OCULUS INC.

Report date July 21, 2020 · Filed August 24, 2020

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $0.26 · Expires 2023-07-21Direct210,000 Reported balance After 2020-07-21 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2020-07-21 · Grant · Acquired 210,000 · Balance 210,000

F1: The exercise price reported above was converted from the Canadian exercise price of C$0.35 using an exchange rate of C$1.34460=US$1.00

F2: Options were granted on July 21,2020 and vest as follows: 20% on January 21,2021; 20% on July 21,2021; 20% on January 21,2022; 20% on July 21,2022 and 20% on January 21,2023.

Filing footnotes · ownership attribution and instrument terms

F1: The exercise price reported above was converted from the Canadian exercise price of C$0.35 using an exchange rate of C$1.34460=US$1.00

F2: Options were granted on July 21,2020 and vest as follows: 20% on January 21,2021; 20% on July 21,2021; 20% on January 21,2022; 20% on July 21,2022 and 20% on January 21,2023.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
July 21, 2020 Filed Aug 24, 2020 23:53 UTC OCULUS INC. OTCQB · Entity 8451 GrantStock Options · Derivative 210,000 $0.00 Strike: $0.26 $0.00
Disclosure

SEC source: 0001816084-20-000003 · primary_doc.xml · derivative · entry 1

Johnson Michael Patrick · CIK 0001816084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 210,000

Underlying: Common Stock · 210,000 shares

Expires 2023-07-21

F1 · derivative.exercise_price: The exercise price reported above was converted from the Canadian exercise price of C$0.35 using an exchange rate of C$1.34460=US$1.00

F2 · derivative.exercise_date: Options were granted on July 21,2020 and vest as follows: 20% on January 21,2021; 20% on July 21,2021; 20% on January 21,2022; 20% on July 21,2022 and 20% on January 21,2023.

Read SEC document
June 05, 2020 Filed Jun 25, 2020 19:20 UTC OCULUS INC. OVTZ · Entity 8451 PurchaseWarrants · Derivative 1,875,000 $0.11 Strike: $0.11 $204,375.00
Disclosure

SEC source: 0001816084-20-000002 · primary_doc.xml · derivative · entry 2

Johnson Michael Patrick · CIK 0001816084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,875,000

Underlying: Common Shares · 1,875,000 shares

Expires 2025-06-04

Read SEC document
June 05, 2020 Filed Jun 25, 2020 19:20 UTC OCULUS INC. OVTZ · Entity 8451 PurchaseCommon Shares 1,875,000 $0.11 $204,375.00
Disclosure

SEC source: 0001816084-20-000002 · primary_doc.xml · nonDerivative · entry 1

Johnson Michael Patrick · CIK 0001816084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,875,000

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.